Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Management of Chronic Kidney Disease Stages 1–3

Slides: 13–24 of 29

Clinical Bottom Line: Risk for ESRD in Patients With CKD Stages 1–3 Treated With ACEIs

Clinical Bottom Line: Risk for ESRD in Patients With CKD Stages 1–3 Treated With ARBs

Clinical Bottom Line: Risk for ESRD in Patients With CKD Stages 1–3 Treated With Other Interventions

Clinical Bottom Line: Risk for Mortality in Patients With CKD Stages 1–3 Treated With ACEIs or ARBs (1 of 2)

Clinical Bottom Line: Risk for Mortality in Patients With CKD Stages 1–3 Treated With ACEIs or ARBs (2 of 2)

Clinical Bottom Line: Risk for Mortality in Patients With CKD Stages 1–3 Treated With Statins

Clinical Bottom Line: Risk for Mortality in Patients With CKD Stages 1–3 Treated With Beta-Blockers

Clinical Bottom Line: Risk for Mortality in Patients With CKD Stages 1–3 Treated With Other Interventions

Adverse Events of Treatment

Clinical Bottom Line: Screening and Monitoring

Clinical Bottom Line: Screening and Monitoring in Subpopulations

Conclusions: Treatment (1 of 2)

Pages: Previous 1 [2] 3 Next